The court also ruled that the Edwards SAPIEN 3 valve infringes two of Boston Scientific's patents for outer …
Edwards Lifesciences
Then we have Chairman of the board Mark Eaton, a well-known head of sales for CIBC in Toronto whose last success was Belo Sun Mining …
Kensington Market
Investors Spotlight: Boston Scientific Corporation (NYSE:BSX) The last close places the company's stock about $1.51 off its 52 week high of …
FDA
Boston Scientific (BSX) was trading at $20.80 on November 29, 2016. It had a 50-day moving average of $21.90 and a 200-day moving average of $23.10. The company has witnessed a turnaround since hitting its low after …
Investors in Boston Scientific Corp. (NYSE: BSX) saw new options begin trading today, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BSX options chain …
Breaking those down we see that the ratings are as follows: 14 Strong Buy, 3 Rated Buy, 5 Rated Hold and 0 Rated Sell. The analysts wrote, "This morning BSX filed an 8-K noting that it announced a voluntary removal of …
Boston Scientific Corporation (NYSE:BSX) [Trend Analysis], stock fell down to knees around -1.03% in early session as its gaining volume of …
Rating Reiterated
Boston Scientific's ( BSX) stock price has shot up by approximately 5% following its Q4'16 earnings announcement. This is because the company's revenues in the quarter were slightly above its previously …
NASDAQ1mon
NASDAQ
Boston Scientific removed its Lotus Edge Valve System device from the European market last fall, and it said similar issues — “excess tension in the pin mechanism” — had caused both events. The news sent the stock
Boston Scientific